Non-Small Cell Lung Cancer and Quality of Life - Full Text View

Non-Small Cell Lung Cancer and Quality of Life (SILKE)

This study is currently recruiting participants.

Verified by University of Turku, January 2009

Sponsored by:	University of Turku
Information provided by:	University of Turku
ClinicalTrials.gov Identifier:	NCT00818402

Purpose

The principal objective is to study clinical observations, symptoms and quality of life of non-small-cell lung cancer (NSCLC) patients undergoing specific non-operative treatment for cancer, including chemotherapy and radiotherapy.

Condition
Non Small Cell Lung Cancer

MedlinePlus related topics: Cancer Lung Cancer

U.S. FDA Resources

Study Type:	Observational
Study Design:	Case-Only, Prospective
Official Title:	Treatment of Non-Small Cell Lung Cancer -Effects on Quality of Life and Symptom Control

Further study details as provided by University of Turku:

Biospecimen Retention: Samples With DNA

Biospecimen Description:

whole blood

Estimated Enrollment:	200
Study Start Date:	August 2008
Estimated Study Completion Date:	September 2011
Estimated Primary Completion Date:	September 2011 (Final data collection date for primary outcome measure)

Groups/Cohorts
Non-small cell lung cancer patients

Eligibility

Ages Eligible for Study:	18 Years and older
Genders Eligible for Study:	Both
Accepts Healthy Volunteers:	No
Sampling Method:	Non-Probability Sample

Study Population

The patients treated in the clinic of respiratory medicine in Turku, Finland

Criteria

Inclusion Criteria:

Patients with verified NSCLC
after the NSCLC diagnosis has been confirmed prior to first chemotherapy or radiotherapy
Finnish speaking patients
aged 18 years or more
Written informed consent has to be signed

Exclusion Criteria:

Patients not consenting to participate in the study
patients not able to communicate sufficiently
cancer type is other than non-small-cell lung cancer

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00818402

Contacts

Contact: Maria Silvoniemi, MD

+358 50 3442175

marber@utu.fi

Locations

Finland
Turku University Hospital, the Clinic of Resperatory Medicine	Recruiting
Turku, Finland, 20521
Contact: Maria Silvoniemi marber@utu.fi

Sponsors and Collaborators

University of Turku

More Information

Responsible Party:	University of Turku ( MD Maria Silvoniemi )
Study ID Numbers:	SILKE-ETMK:47/180/2008
Study First Received:	January 5, 2009
Last Updated:	January 6, 2009
ClinicalTrials.gov Identifier:	NCT00818402
Health Authority:	Finland: Ethics Committee

Keywords provided by University of Turku:

Quality of life
symptoms

Study placed in the following topic categories:

Thoracic Neoplasms
Non-small cell lung cancer
Respiratory Tract Diseases
Lung Neoplasms
Lung Diseases

Quality of Life
Carcinoma, Non-Small-Cell Lung
Neoplasms, Glandular and Epithelial
Carcinoma

Additional relevant MeSH terms:

Respiratory Tract Neoplasms
Neoplasms
Neoplasms by Site
Neoplasms by Histologic Type

ClinicalTrials.gov processed this record on January 13, 2009